Nanosonics Limited

PINK:NNCSF USA Medical Instruments & Supplies
Market Cap
$843.30 Million
Market Cap Rank
#8665 Global
#4323 in USA
Share Price
$2.78
Change (1 day)
+0.00%
52-Week Range
$2.65 - $2.78
All Time High
$6.17
About

Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It… Read more

Nanosonics Limited (NNCSF) - Total Assets

Latest total assets as of June 2025: $272.48 Million USD

Based on the latest financial reports, Nanosonics Limited (NNCSF) holds total assets worth $272.48 Million USD as of June 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Nanosonics Limited - Total Assets Trend (2013–2025)

This chart illustrates how Nanosonics Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Nanosonics Limited - Asset Composition Analysis

Current Asset Composition (June 2025)

Nanosonics Limited's total assets of $272.48 Million consist of 82.7% current assets and 17.3% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 59.2%
Accounts Receivable $38.24 Million 14.0%
Inventory $18.63 Million 6.8%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $1.00K 0.0%
Goodwill $0.00 0.0%

Asset Composition Trend (2013–2025)

This chart illustrates how Nanosonics Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Nanosonics Limited's current assets represent 82.7% of total assets in 2025, a decrease from 94.1% in 2013.
  • Cash Position: Cash and equivalents constituted 59.2% of total assets in 2025, down from 71.5% in 2013.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2013.
  • Asset Diversification: The largest asset category is accounts receivable at 14.0% of total assets.

Nanosonics Limited Competitors by Total Assets

Key competitors of Nanosonics Limited based on total assets are shown below.

Company Country Total Assets
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
China CN¥3.82 Billion
Blue Sail Medical Co Ltd
SHE:002382
China CN¥16.46 Billion
Andon Health Co Ltd
SHE:002432
China CN¥28.98 Billion
Allmed Medical Products Co Ltd Class A
SHE:002950
China CN¥5.35 Billion
Inix Technologies Holdings Bhd
KLSE:0094
Malaysia RM72.53 Million
Focus Point Holdings Bhd
KLSE:0157
Malaysia RM328.19 Million
Careplus Group Bhd
KLSE:0163
Malaysia RM286.61 Million
LKL International Bhd
KLSE:0182
Malaysia RM173.46 Million

Nanosonics Limited - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.55 - 0.74

Strong asset utilization - Nanosonics Limited generates 0.73x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: 0.18% - 26.29%

Solid ROA - For every $100 in assets, Nanosonics Limited generates $7.59 in net profit.

Nanosonics Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 5.66 6.16 6.90
Quick Ratio 5.19 5.53 6.24
Cash Ratio 0.00 0.00 0.00
Working Capital $185.53 Million $ 166.22 Million $ 106.30 Million

Nanosonics Limited - Advanced Valuation Insights

This section examines the relationship between Nanosonics Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.45
Latest Market Cap to Assets Ratio 2.62
Asset Growth Rate (YoY) 14.8%
Total Assets $272.48 Million
Market Capitalization $714.50 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Nanosonics Limited's assets at a significant premium ( 2.62x), suggesting investors see substantial growth potential or unique competitive advantages.

Rapid Asset Growth: Nanosonics Limited's assets grew by 14.8% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Nanosonics Limited (2013–2025)

The table below shows the annual total assets of Nanosonics Limited from 2013 to 2025.

Year Total Assets Change
2025-06-30 $272.48 Million +14.81%
2024-06-30 $237.34 Million +4.98%
2023-06-30 $226.07 Million +16.99%
2022-06-30 $193.24 Million +17.42%
2021-06-30 $164.57 Million +11.03%
2020-06-30 $148.23 Million +13.65%
2019-06-30 $130.42 Million +18.34%
2018-06-30 $110.21 Million +10.78%
2017-06-30 $99.48 Million +45.93%
2016-06-30 $68.17 Million +12.93%
2015-06-30 $60.37 Million +79.96%
2014-06-30 $33.54 Million -0.32%
2013-06-30 $33.65 Million --